Michael has studied chemistry and biology with a Ph.D. from ETH Zurich. He has significant experience from previous R&D roles at leading industrial Life Science organisations in metabolic and cardiovascular health.
A serial entrepreneur, Michael has led several start-up companies to profitability, including Siegfried Biologics, Kuros Biosciences and ChromaCon. Besides his assignment with Galventa, Michael is engaged in helping a Venture boutique company, Remora Capital to launch new start-up companies in the field of Cancer/Immunology and Healthy Aging.
Having a specific interest in nutraceuticals and healthy aging, Michael works on developing new products, focusing on manufacturing, regulatory and quality issues.
Michael supports organizations for disabled children and likes to meet his friends and extended family members to celebrate occasions as they occur. Michael enjoys studying art and history of late antiquity and is fond of classical music.
Purification of Synthetic Peptides
Twin-Column Cation Exchange Chromatography For The Purification Of Biomolecules
Affinity Capture of FAB Fragments: Using Twin-Column Countercurrent Chromatography
Increasing Capacity Utilization in Protein A Chromatography
Productivity Boost For Biopurification
Purifying Common Light-Chain Bispecific Antibodies
The hepatitis B virus-associated reverse transcriptase is encoded by the viral pol gene
Two proteins with reverse transcriptase activities associated with hepatitis B virus-like particles
Structure-function studies on the human immunodeficiency virus type 1 reverse transcriptase
As the warmth of summer slowly gives way to the crispness of autumn, the familiar refrain of back-to-school season echoes through the air. For students of all ages, this seasonal...
As the calendar turns to September, and the leaves begin to change, we welcome the arrival of "Sleeptember." This month marks a unique opportunity for individuals to embrace the transformative...